(Reuters) - Pfizer Inc has agreed to pay $325 million to resolve claims it defrauded insurers and other healthcare benefit providers by marketing Neurontin for
Pfizer Accused of "Blatant Hypocrisy" Over Alleged Witness Tampering in Neurontin Case - CBS News
A $190 million settlement has been reached in New York in a consumer fraud class action lawsuit pending against Pfizer which alleges the pharma giant engaged in tactics to
A Pfizer spokesperson told The Associated Press that its clinical trial was designed to evaluate the efficacy of its COVID-19 vaccine in preventing disease caused
Alcohol can increase the nervous system side effects of gabapentin such as dizziness, drowsiness, and difficulty concentrating
I believe there should be a class action lawsuit because they have misrepresented gabapentin
Data were collected to the point of saturation of key themes and analyzed using Texas attorney general Ken Paxton has filed a lawsuit against the pharmaceutical giant Pfizer, claiming the company lied about the effectiveness of its COVID-19 vaccine
In 2016, Pfizer confirmed by telephone that it has no plans to publish additional data or analyses from trials of gabapentin for neuropathic pain
Paul D Thacker reports In autumn 2020 Pfizer’s chairman and chief executive, Albert Bourla, released an open letter to the billions of people around the world who were
Pfizer Inc
Gabapentin is a widely used antiepileptic drug that has been linked to increased risk of suicidality in some studies
That’s the claim in a news report by South African TV broadcaster eNCA that’s been getting social media attention since October 2022
IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING
Watch for breathing issues In the latest settlement of a Big Pharma-delays-generics case, Pfizer has agreed to pay $190 million to wrap up a class-action suit over its seizure drug Neurontin